Compare iShares MSCI South Korea ETF (EWY) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI South Korea ETF vs 22nd Century Group Inc — how do they compare? iShares MSCI South Korea ETF trades at $177.22 (market cap $26.25B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: iShares MSCI South Korea ETF is far larger — about 42225× 22nd Century Group Inc's market cap, and iShares MSCI South Korea ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI South Korea ETF for 47 Days and 22nd Century Group Inc for 32 Days on average.
| EWY | XXII | |
|---|---|---|
Market Cap | $26.25B | $621.67K |
Volume | 19,056,075 | 45,625 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $219.20 | $483.00 |
52-Week Low | $80.72 | $0.80 |
Typical Hold Time | 47 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWY, the iShares MSCI South Korea ETF, trades at $177.22, down 3.54% amid broad Asian market pressure from rising oil prices and US Treasury yields. Technical indicators show a bearish trend with support at $174 and resistance at $179, while RSI levels suggest potential oversold conditions. The ETF remains heavily concentrated in Samsung and SK hynix, benefiting from AI-driven memory demand but vulnerable to semiconductor cycle volatility.
Outlook remains cautious as geopolitical tensions and high concentration risk offset strong AI fundamentals. The ETF's 148% YoY gain highlights growth potential, but investors face headwinds from global monetary tightening and oil price shocks. Key catalysts include semiconductor investment developments and US-Korea trade relations.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI South Korea ETF
EWY tracks the MSCI Korea 25/50 Index, offering targeted exposure to large and mid-cap companies in South Korea. It is structurally centered on the global technology supply chain, industrials, and financial services, serving as a liquid tool for investors seeking a single-country view of this advanced, innovation-led economy.
Read more on EWY →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
